<DOC>
	<DOCNO>NCT00804414</DOCNO>
	<brief_summary>Evaluation efficacy safety SBG v placebo treatment chronic diabetic foot ulcer .</brief_summary>
	<brief_title>Efficacy Safety Study Soluble Beta-1,3/1,6-glucan ( SBG ) Versus Placebo Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description>The objective study evaluate efficacy safety soluble beta-1,3/1,6-glucan ( SBG ) chronic diabetic foot ulcer .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Patients chronic diabetic foot ulcer Insufficient nutritional status , renal function diabetes control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Diabetic ulcer</keyword>
	<keyword>Chronic ulcer</keyword>
	<keyword>SBG</keyword>
</DOC>